Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients
This study is currently recruiting participants.
Verified by University Hospital, Geneva, September 2006
Sponsored by: University Hospital, Geneva
Information provided by: University Hospital, Geneva
ClinicalTrials.gov Identifier: NCT00160823
  Purpose

The quality of colon cleansing has a major impact on efficiency and cost of colonoscopy. A hand-out was made to instruct and motivate patients to adequately clean the bowel before colonoscopy.

The aim of the study is to compare adequacy of bowel cleansing in hospitalized patients receiving the hand-out or not on the day before colonoscopy.


Condition Intervention Phase
Colonoscopy
Procedure: Self-administered leaflet
Phase III

U.S. FDA Resources
Study Type: Interventional
Study Design: Diagnostic, Randomized, Single Blind, Placebo Control, Factorial Assignment, Efficacy Study
Official Title: Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital

Further study details as provided by University Hospital, Geneva:

Primary Outcome Measures:
  • Quality of overall colon cleansing

Secondary Outcome Measures:
  • Quality of cleansing in the ascending colon,
  • Frequency of inadequate preparation and of failed procedure,
  • Time to intubate the caecum,
  • Cost-effectiveness of the self-administered leaflet,
  • Patient compliance with the self-administered leaflet,
  • Patient comfort with the colonoscopy.

Estimated Enrollment: 102
Study Start Date: September 2005
  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Total colonoscopy scheduled during hospital stay in the Hôpital Universitaire de Genève (excluding dependencies);
  • Informed consent for inclusion in the study signed by the patient;
  • Ability to read and write at least one of the following languages : French, English, Spanish, Portuguese.

Exclusion Criteria:

  • Colonoscopy scheduled under general anesthesia;
  • Occupation inside the healthcare professions;
  • Previous colonoscopy, colostomy or colectomy;
  • Megacolon or idiopathic pseudo-obstruction.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00160823

Contacts
Contact: Jean-Marc Dumonceau, MD,PhD +41223729340 jmdumonceau@hotmail.com
Contact: Jean-Marc Dumonceau 0797645586 jean-Marc.Dumonceau@hcuge.ch

Locations
Switzerland
Gastroenterology and Hepatology Division, University Hospital of Geneva Recruiting
Geneva, Switzerland, 1205
Contact: Jean-Marc Dumonceau, MD,PhD     + 41 22 372 93 40     jmdumonceau@hotmail.com    
Principal Investigator: JM Dumonceau, MD,PhD            
Sponsors and Collaborators
University Hospital, Geneva
Investigators
Study Chair: Jean-Marc Dumonceau, MD,PhD University Hospital of Geneva
  More Information

Study ID Numbers: 04-147
Study First Received: September 8, 2005
Last Updated: September 11, 2006
ClinicalTrials.gov Identifier: NCT00160823  
Health Authority: Switzerland: Swissmedic

Keywords provided by University Hospital, Geneva:
Colon cleansing
Quality
Cost-effectiveness

ClinicalTrials.gov processed this record on January 16, 2009